ANXA1 and nasal cavity polyp: In chronic inflammation, the expression of ANXA1 is also positively modulated in human epithelial cells in nasal polyps cases after treatment with glucocorticoids, suggesting an inhibitory role of ANXA1 in epithelial proliferation, which is common to this pathology [19].